个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
J.Li[1] * ;
机构： [1]Sichuan Province Cancer Hospital, Chengdu/CN
出处：
ISSN：

关键词： stage III nonsmall cell lung cancer neoadjuvant immunotherapy low dose radiation therapy

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Sichuan Province Cancer Hospital, Chengdu/CN
推荐引用方式(GB/T 7714)：
J.Li.A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC[J].JOURNAL OF THORACIC ONCOLOGY.2021,16(10):S1049-S1050.
APA：
J.Li.(2021).A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC.JOURNAL OF THORACIC ONCOLOGY,16,(10)
MLA：
J.Li."A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC".JOURNAL OF THORACIC ONCOLOGY 16..10(2021):S1049-S1050

相关文献

[1]Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome. [2]Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques [3]Pulsed Low-Dose-Rate External Beam Radiation Therapy: An in-vivo Study on Prostate Cancer [4]Low Radiation Therapy Dose of Cardiac and Descending Aorta are Associated with the Worst Grade of Radiation-Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [5]Pulsed Low-Dose-Rate Radiation Therapy (PLDR) for Recurrent Cancers: Treatment Planning Strategies for IMRT and VMAT [6]Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose-Rate Radiation Therapy (PLRT) for Recurrent Lung Cancer: An In Vivo Study [7]SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial [8]调强放射治疗在头颈部肿瘤脉冲式低剂量率放射治疗中的可行性 [9]Corrigendum: Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation. [10]Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

资源点击量：53080 今日访问量：0 总访问量：4588 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号